Autopsy report · NCT05208138

Feasibility and Safety of Robotic Bariatric Surgery Using the SenhanceTM Surgical System

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“leasing of the Senhance system ended”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 5 months before it stopped.
21 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Insel Gruppe AG, University Hospital Bern
Sponsor type: University, hospital or other
Conditions: Bariatric Surgery Candidate
Interventions: Senhance Surgical System from Asensus
Participants: 21
Sites: 1
Countries: Switzerland

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.